Acute Leukemias - Republican Scientific Medical Library
Acute Leukemias - Republican Scientific Medical Library
Acute Leukemias - Republican Scientific Medical Library
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
a References 279<br />
10. Leclerc J, Rivard G, Blanch M, et al. (1988) The association of once a<br />
day high-dose Ara-C followed by mitoxantrone for 3 days induces<br />
a high rate of complete remission in children with poor prognosis<br />
acute leukemia. Blood 72(Suppl):210 (abstr)<br />
11. Kantarjian H, Walters R, Keating M, et al. (1990) Mitoxantrone and<br />
high-dose cytosine arabinoside for the treatment of refractory<br />
acute lymphocytic leukemia. Cancer 65:5–8<br />
12. Feldman EJ, Alberts DS, Arlin Z, et al. (1993) Phase I clinical and<br />
pharmacokinetic evaluation of high-dose mitoxantrone in combination<br />
with cytarabine in patients with acute leukemia. J Clin Oncol<br />
11:2002–2009<br />
13. Weiss MA, Drullinsky P, Maslak P, et al. (1998) A phase I trial of a<br />
single high dose of idarubicin combined with high-dose cytarabine<br />
as induction therapy in relapsed or refractory adult patients<br />
with acute lymphoblastic leukemia. Leukemia 12(6):865–868<br />
14. Weiss MA, Aliff TB, Tallman MS, et al. (2002) A single, high dose of<br />
idarubicin combined with cytarabine as induction therapy for<br />
adult patients with recurrent or refractory acute lymphoblastic<br />
leukemia. Cancer 95(3):581–587<br />
15. Davies SM, Ramsay NK, Weisdorf DJ (1996) Feasibility and timing<br />
of unrelated donor identification for patients with ALL. Bone Marrow<br />
Transplant 17:737–740<br />
16. Gale RP, Horowitz MM, Ash RC, et al. (1994) Identical-twin bone<br />
marrow transplants for leukemia. Ann Intern Med 120:646–652<br />
17. Kolb H-J, Schattenberg A, Goldman JM, et al. (1995) Graft-versusleukemia<br />
effect of donor lymphocyte transfusions in marrow<br />
grafted patients. Blood 86:2041<br />
18. Passweg JR, Tiberghien P, Cahn J-Y, et al. (1998) Graft-versus-leukemia<br />
effects in T lineage and B lineage acute lymphoblastic leukemia.<br />
Bone Marrow Transplant 21:153–158<br />
19. Doney K, Fisher LD, Appelbaum FR, et al. (1991) Treatment of adult<br />
acute lymphoblastic leukemia with allogeneic bone marrow<br />
transplantation. Multivariate analysis of factors affecting acute<br />
graft-versus-host disease, relapse, and relapse-free survival. Bone<br />
Marrow Transplant 7:453–459<br />
20. Weisdorf DJ, Woods WG, Nesbit ME Jr, et al. (1994) Allogeneic<br />
bone marrow transplantation for acute lymphoblastic leukemia:<br />
Risk factors and clinical outcome. Br J Haematol 86:62–69<br />
21. Sebban C, Lepage E, Vernant J-P, et al. (1994) Allogeneic bone<br />
marrow transplantation for acute lymphoblastic leukemia in first<br />
complete remission: A comparative study. J Clin Oncol 12:2580–<br />
2587<br />
22. Zhang M-J, Hoelzer D, Horowitz MM, et al. (1995) Long-term follow-up<br />
of adults with acute lymphoblastic leukemia in first remission<br />
treated with chemotherapy or bone marrow transplantation.<br />
Ann Intern Med 123:428–431<br />
23. Attal M, Blaise D, Marit G, et al. (1995) Consolidation treatment of<br />
adult acute lymphoblastic leukemia: A prospective, randomized<br />
trial comparing allogeneic versus autologous bone marrow transplantation<br />
and testing the impact of recombinant interleukin-2<br />
after autologous bone marrow transplant. Blood 86:1619–1628<br />
24. Thiebaut A, Vernant JP, Degos L, et al. (2000) Adult acute lymphocytic<br />
leukemia study testing chemotherapy and autologous and<br />
allogeneic transplantation. A follow-up report of the French protocol<br />
LALA 87 (Review). Hematol Oncol Clin N Amer 14:1353–<br />
1366<br />
25. Fiere D, Lepage E, Sebban C, et al. (1993) Adult acute lymphoblastic<br />
leukemia: A multicentric randomized trial testing bone marrow<br />
transplantation as postremission therapy. J Clin Oncol 11:1990–<br />
2001<br />
26. Barrett AJ, Horowitz, MM, Ash RC, et al. (1992) Bone marrow transplantation<br />
for Philadelphia chromosome-positive acute lymphoblastic<br />
leukemia. Blood 79:3067–3070<br />
27. Dombret H, Gabert J, Boiron JM, et al. (2002) Outcome of treatment<br />
in adults with Philadelphia chromosome-positive acute lymphoblastic<br />
leukemia: Results of the prospective multicenter LALA-<br />
94 trial. Blood 100:2357–2366<br />
28. Druker BJ, Talpaz M, Resta DJ, et al. (2001) Efficacy and safety of a<br />
specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid<br />
leukemia. N Engl J Med 344:1031–1037<br />
29. Ottmann OG, Druker BJ, Sawyers CL, et al. (2002) A phase 2 study<br />
of imatinib in patients with relapsed or refractory Philadelphia<br />
chromosome-positive acute lymphoid leukemias. Blood 100:<br />
1965–1971<br />
30. Hoffman WK, Jones JC, Lemp NA, et al. (2002) Ph+ acute lymphoblastic<br />
leukemia resistant to the tyrosine kinase inhibitor STI571<br />
has a unique BCR-ABL gene mutation. Blood 99:1860–1862<br />
31. Hoffman WK, Komor M, Wassman B, et al. (2003) Presence of the<br />
BCR-ABL mutation Glu255Lys prior to STI571 (imatinib) treatment<br />
in patients with Ph+ acute lymphoblastic leukemia. Blood 102:<br />
659–661<br />
32. Thomas DA, Faderl S, Cortes J, et al. (2004) Treatment of Philadelphia<br />
chromosome-positive acute lymphocytic leukemia with hyper-CVAD<br />
and imatinib mesylate. Blood 103(12):4396–4407<br />
33. Wassmann B, Scheuring U, Pfeifer H, et al. (2003) Efficacy and<br />
safety of imatinib mesylate (Glivec) in combination with interferon-alpha<br />
(IFN-alpha) in Philadelphia chromosome-positive acute<br />
lymphoblastic leukemia (Ph+ ALL). Leukemia 17:1919–1924<br />
34. Sanders KE, Ha CS, Cortes-Franco JE, et al. (2004) The role of<br />
craniospinal irradiation in adults with a central nervous system<br />
recurrence of leukemia. Cancer 100:2160–2180<br />
35. Kantarjian H, Gandhi V, Cortes J, et al. (2001) Phase 2 clinical and<br />
pharmacologic study of clofarabine in patients with refractory or<br />
relapsed acute leukemia. Blood 103:2379<br />
36. Gandhi V, Plunkett W, Rodriguez CO Jr, et al. (1998) Compound<br />
GW506U78 in refractory hematologic malignancies: Relationship<br />
between cellular pharmacokinetics and clinical response. J Clin<br />
Oncol 16:3607–3615<br />
37. Gandhi V, Plunkett W, Weller S, et al. (2001) Evaluation of the combination<br />
of nelarabine and fludarabine in leukemias: clinical response,<br />
pharmacokinetics, and pharmacodynamics in leukemia<br />
cells. J Clin Oncol 19(8):2142–2152